Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 344 entries
Sorted by: Best Match Show Resources per page
What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study.

Rheumatology international

Weddell J, Hider SL, Mallen CD, Muller S.
PMID: 34677651
Rheumatol Int. 2021 Oct 22; doi: 10.1007/s00296-021-05036-6. Epub 2021 Oct 22.

Polymyalgia rheumatica (PMR) is common. The mainstay of treatment, glucocorticoids, are associated with significant adverse effects and many patients remain on high doses for a number of years. Little is known about the use of other, non-pharmacological therapies as...

Cite
Weddell J, Hider SL, Mallen CD, et al. What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study. Rheumatol Int. 2021;doi: 10.1007/s00296-021-05036-6.
Weddell, J., Hider, S. L., Mallen, C. D., & Muller, S. (2021). What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study. Rheumatology international, . https://doi.org/10.1007/s00296-021-05036-6
Weddell, Jake, et al. "What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-05036-6
Weddell J, Hider SL, Mallen CD, Muller S. What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study. Rheumatol Int. 2021 Oct 22; doi: 10.1007/s00296-021-05036-6. Epub 2021 Oct 22. PMID: 34677651.
Copy Download .nbib Format: NLM
Familial coexistence of demyelinating diseases and familial Mediterranean fever.

Rheumatology international

Korkmaz C, Üsküdar Cansu D, Kabay SC.
PMID: 33715072
Rheumatol Int. 2021 Mar 13; doi: 10.1007/s00296-021-04821-7. Epub 2021 Mar 13.

Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disease characterized by fever and serositis attacks caused by mutations in the MEditerranean FeVer (MEFV) gene encoding the pyrin gene. Gain of the function mutations of the pyrin gene lead to...

Cite
Korkmaz C, Üsküdar Cansu D, Kabay SC. Familial coexistence of demyelinating diseases and familial Mediterranean fever. Rheumatol Int. 2021;doi: 10.1007/s00296-021-04821-7.
Korkmaz, C., Üsküdar Cansu, D., & Kabay, S. C. (2021). Familial coexistence of demyelinating diseases and familial Mediterranean fever. Rheumatology international, . https://doi.org/10.1007/s00296-021-04821-7
Korkmaz, Cengiz, et al. "Familial coexistence of demyelinating diseases and familial Mediterranean fever." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-04821-7
Korkmaz C, Üsküdar Cansu D, Kabay SC. Familial coexistence of demyelinating diseases and familial Mediterranean fever. Rheumatol Int. 2021 Mar 13; doi: 10.1007/s00296-021-04821-7. Epub 2021 Mar 13. PMID: 33715072.
Copy Download .nbib Format: NLM
Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis.

Rheumatology international

Bekele DI, Cheng E, Reimold A, Geier C, Ganuthula K, Walsh JA, Clegg DO, Dubreuil M, Kaushik P, Ng B, Chang E, Duong R, Park J, Kerr GS.
PMID: 34724089
Rheumatol Int. 2021 Nov 01; doi: 10.1007/s00296-021-05024-w. Epub 2021 Nov 01.

Although tumor necrosis factor inhibitors (TNFi) have favorably altered the treatment landscape for patients with axial spondyloarthritis (axSpA), there is limited data regarding TNFi persistence and reasons for discontinuation. This is an observational time-to-event study utilizing data collected for...

Cite
Bekele DI, Cheng E, Reimold A, et al. Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis. Rheumatol Int. 2021;doi: 10.1007/s00296-021-05024-w.
Bekele, D. I., Cheng, E., Reimold, A., Geier, C., Ganuthula, K., Walsh, J. A., Clegg, D. O., Dubreuil, M., Kaushik, P., Ng, B., Chang, E., Duong, R., Park, J., & Kerr, G. S. (2021). Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis. Rheumatology international, . https://doi.org/10.1007/s00296-021-05024-w
Bekele, Delamo I, et al. "Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-05024-w
Bekele DI, Cheng E, Reimold A, Geier C, Ganuthula K, Walsh JA, Clegg DO, Dubreuil M, Kaushik P, Ng B, Chang E, Duong R, Park J, Kerr GS. Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis. Rheumatol Int. 2021 Nov 01; doi: 10.1007/s00296-021-05024-w. Epub 2021 Nov 01. PMID: 34724089.
Copy Download .nbib Format: NLM
Long-lasting severe knee pain in a SLE patient after renal transplantation: what is the reason? A case report and literature review.

Rheumatology international

Masiak A, Kościńska I, Rutkowska B, Zdrojewski Z.
PMID: 34665297
Rheumatol Int. 2021 Oct 19; doi: 10.1007/s00296-021-05018-8. Epub 2021 Oct 19.

Musculo-skeletal complaints in a patient suffering from systemic lupus, with co-existing chronic renal failure, undergoing immunosuppressive treatment after kidney transplantation, can have a varied etiology. The aim of this work was to present a case based review of differential...

Cite
Masiak A, Kościńska I, Rutkowska B, et al. Long-lasting severe knee pain in a SLE patient after renal transplantation: what is the reason? A case report and literature review. Rheumatol Int. 2021;doi: 10.1007/s00296-021-05018-8.
Masiak, A., Kościńska, I., Rutkowska, B., & Zdrojewski, Z. (2021). Long-lasting severe knee pain in a SLE patient after renal transplantation: what is the reason? A case report and literature review. Rheumatology international, . https://doi.org/10.1007/s00296-021-05018-8
Masiak, Anna, et al. "Long-lasting severe knee pain in a SLE patient after renal transplantation: what is the reason? A case report and literature review." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-05018-8
Masiak A, Kościńska I, Rutkowska B, Zdrojewski Z. Long-lasting severe knee pain in a SLE patient after renal transplantation: what is the reason? A case report and literature review. Rheumatol Int. 2021 Oct 19; doi: 10.1007/s00296-021-05018-8. Epub 2021 Oct 19. PMID: 34665297.
Copy Download .nbib Format: NLM
Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis.

Rheumatology international

Iliopoulos G, Daoussis D.
PMID: 33844037
Rheumatol Int. 2021 Jul;41(7):1203-1208. doi: 10.1007/s00296-021-04855-x. Epub 2021 Apr 12.

Research regarding renal involvement in SSc has almost exclusively focused on scleroderma renal crisis (SRC). There are relatively limited data regarding renal impairment in SSc beyond SRC. We performed an electronic search using the key words systemic sclerosis or...

Cite
Iliopoulos G, Daoussis D. Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis. Rheumatol Int. 2021;41(7):1203-1208doi: 10.1007/s00296-021-04855-x.
Iliopoulos, G., & Daoussis, D. (2021). Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis. Rheumatology international, 41(7), 1203-1208. https://doi.org/10.1007/s00296-021-04855-x
Iliopoulos, George, and Daoussis, Dimitrios. "Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis." Rheumatology international vol. 41,7 (2021): 1203-1208. doi: https://doi.org/10.1007/s00296-021-04855-x
Iliopoulos G, Daoussis D. Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis. Rheumatol Int. 2021 Jul;41(7):1203-1208. doi: 10.1007/s00296-021-04855-x. Epub 2021 Apr 12. PMID: 33844037.
Copy Download .nbib Format: NLM
Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review.

Rheumatology international

Masiak A, Lass A, Kowalski J, Hajduk A, Zdrojewski Z.
PMID: 35024942
Rheumatol Int. 2022 Jan 13; doi: 10.1007/s00296-021-05088-8. Epub 2022 Jan 13.

BACKGROUND: The association between COVID-19 infection and the development of autoimmune diseases is currently unknown, but there are already reports presenting induction of different autoantibodies by SARS-CoV-2 infection. Kikuchi-Fuimoto disease (KFD) as a form of histiocytic necrotizing lymphadenitis of...

Cite
Masiak A, Lass A, Kowalski J, et al. Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review. Rheumatol Int. 2022;doi: 10.1007/s00296-021-05088-8.
Masiak, A., Lass, A., Kowalski, J., Hajduk, A., & Zdrojewski, Z. (2022). Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review. Rheumatology international, . https://doi.org/10.1007/s00296-021-05088-8
Masiak, Anna, et al. "Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review." Rheumatology international vol. (2022). doi: https://doi.org/10.1007/s00296-021-05088-8
Masiak A, Lass A, Kowalski J, Hajduk A, Zdrojewski Z. Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review. Rheumatol Int. 2022 Jan 13; doi: 10.1007/s00296-021-05088-8. Epub 2022 Jan 13. PMID: 35024942.
Copy Download .nbib Format: NLM
Assessment of the responsiveness of four scales in geriatric patients with chronic neck pain.

Rheumatology international

Akaltun MS, Kocyigit BF.
PMID: 34302231
Rheumatol Int. 2021 Oct;41(10):1825-1831. doi: 10.1007/s00296-021-04957-6. Epub 2021 Jul 23.

The purpose of this study was to evaluate the responsiveness of Copenhagen Neck Functional Disability Scale (CNFDS), Neck Disability Index (NDI), Neck Bournemouth Questionnaire (NBQ), Neck Pain and Disability Scale (NPDS) in geriatric patients with non-specific chronic neck pain....

Cite
Akaltun MS, Kocyigit BF. Assessment of the responsiveness of four scales in geriatric patients with chronic neck pain. Rheumatol Int. 2021;41(10):1825-1831doi: 10.1007/s00296-021-04957-6.
Akaltun, M. S., & Kocyigit, B. F. (2021). Assessment of the responsiveness of four scales in geriatric patients with chronic neck pain. Rheumatology international, 41(10), 1825-1831. https://doi.org/10.1007/s00296-021-04957-6
Akaltun, Mazlum Serdar, and Kocyigit, Burhan Fatih. "Assessment of the responsiveness of four scales in geriatric patients with chronic neck pain." Rheumatology international vol. 41,10 (2021): 1825-1831. doi: https://doi.org/10.1007/s00296-021-04957-6
Akaltun MS, Kocyigit BF. Assessment of the responsiveness of four scales in geriatric patients with chronic neck pain. Rheumatol Int. 2021 Oct;41(10):1825-1831. doi: 10.1007/s00296-021-04957-6. Epub 2021 Jul 23. PMID: 34302231; PMCID: PMC8300983.
Copy Download .nbib Format: NLM
Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.

Rheumatology international

Hiltunen J, Parmanne P, Sokka T, Lamberg T, Isomäki P, Kaipiainen-Seppänen O, Peltomaa R, Uutela T, Pirilä L, Taimen K, Kauppi MJ, Yli-Kerttula T, Tuompo R, Relas H, Kortelainen S, Paalanen K, Asikainen J, Ekman P, Santisteban A, Vidqvist KL, Tadesse K, Romu M, Borodina J, Elfving P, Valleala H, Leirisalo-Repo M, Rantalaiho V, Kautiainen H, Jokiranta TS, Eklund KK.
PMID: 34357455
Rheumatol Int. 2021 Aug 06; doi: 10.1007/s00296-021-04955-8. Epub 2021 Aug 06.

KEY MESSAGES: Considerable proportion of patients with SpA have been immunized to the subcutaneous anti-TNF drug they are using. Concomitant use of MTX protects from immunization, whereas SASP does not. Patients with SpA using subcutaneous anti-TNF drugs can benefit...

Cite
Hiltunen J, Parmanne P, Sokka T, et al. Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis. Rheumatol Int. 2021;doi: 10.1007/s00296-021-04955-8.
Hiltunen, J., Parmanne, P., Sokka, T., Lamberg, T., Isomäki, P., Kaipiainen-Seppänen, O., Peltomaa, R., Uutela, T., Pirilä, L., Taimen, K., Kauppi, M. J., Yli-Kerttula, T., Tuompo, R., Relas, H., Kortelainen, S., Paalanen, K., Asikainen, J., Ekman, P., Santisteban, A., Vidqvist, K. L., Tadesse, K., Romu, M., Borodina, J., Elfving, P., Valleala, H., Leirisalo-Repo, M., Rantalaiho, V., Kautiainen, H., Jokiranta, T. S., Eklund, K. K. (2021). Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis. Rheumatology international, . https://doi.org/10.1007/s00296-021-04955-8
Hiltunen, J, et al. "Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-04955-8
Hiltunen J, Parmanne P, Sokka T, Lamberg T, Isomäki P, Kaipiainen-Seppänen O, Peltomaa R, Uutela T, Pirilä L, Taimen K, Kauppi MJ, Yli-Kerttula T, Tuompo R, Relas H, Kortelainen S, Paalanen K, Asikainen J, Ekman P, Santisteban A, Vidqvist KL, Tadesse K, Romu M, Borodina J, Elfving P, Valleala H, Leirisalo-Repo M, Rantalaiho V, Kautiainen H, Jokiranta TS, Eklund KK. Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis. Rheumatol Int. 2021 Aug 06; doi: 10.1007/s00296-021-04955-8. Epub 2021 Aug 06. PMID: 34357455.
Copy Download .nbib Format: NLM
Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype.

Rheumatology international

Domínguez-Quintana M, Alba MA, Hinojosa-Azaola A.
PMID: 34383129
Rheumatol Int. 2021 Oct;41(10):1717-1728. doi: 10.1007/s00296-021-04966-5. Epub 2021 Aug 12.

The classification of vasculitis according to a schema with universal acceptance is challenging, given the heterogeneous and protean nature of these diseases. Formal nomenclature and classification criteria for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have suffered several changes since...

Cite
Domínguez-Quintana M, Alba MA, Hinojosa-Azaola A. Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype. Rheumatol Int. 2021;41(10):1717-1728doi: 10.1007/s00296-021-04966-5.
Domínguez-Quintana, M., Alba, M. A., & Hinojosa-Azaola, A. (2021). Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype. Rheumatology international, 41(10), 1717-1728. https://doi.org/10.1007/s00296-021-04966-5
Domínguez-Quintana, Maricruz, et al. "Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype." Rheumatology international vol. 41,10 (2021): 1717-1728. doi: https://doi.org/10.1007/s00296-021-04966-5
Domínguez-Quintana M, Alba MA, Hinojosa-Azaola A. Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype. Rheumatol Int. 2021 Oct;41(10):1717-1728. doi: 10.1007/s00296-021-04966-5. Epub 2021 Aug 12. PMID: 34383129.
Copy Download .nbib Format: NLM
Corticosteroid monotherapy for the management of Takayasu arteritis-a systematic review and meta-analysis.

Rheumatology international

Misra DP, Rathore U, Patro P, Agarwal V, Sharma A.
PMID: 34302232
Rheumatol Int. 2021 Oct;41(10):1729-1742. doi: 10.1007/s00296-021-04958-5. Epub 2021 Jul 23.

We evaluated clinical response, normalization of inflammatory markers, angiographic stabilization (primary outcomes), relapses and adverse events (secondary outcomes) in Takayasu arteritis (TAK) patients following corticosteroid monotherapy. MEDLINE, EMBASE, Web of Science, Scopus, Pubmed Central, Cochrane library, clinical trial databases...

Cite
Misra DP, Rathore U, Patro P, et al. Corticosteroid monotherapy for the management of Takayasu arteritis-a systematic review and meta-analysis. Rheumatol Int. 2021;41(10):1729-1742doi: 10.1007/s00296-021-04958-5.
Misra, D. P., Rathore, U., Patro, P., Agarwal, V., & Sharma, A. (2021). Corticosteroid monotherapy for the management of Takayasu arteritis-a systematic review and meta-analysis. Rheumatology international, 41(10), 1729-1742. https://doi.org/10.1007/s00296-021-04958-5
Misra, Durga Prasanna, et al. "Corticosteroid monotherapy for the management of Takayasu arteritis-a systematic review and meta-analysis." Rheumatology international vol. 41,10 (2021): 1729-1742. doi: https://doi.org/10.1007/s00296-021-04958-5
Misra DP, Rathore U, Patro P, Agarwal V, Sharma A. Corticosteroid monotherapy for the management of Takayasu arteritis-a systematic review and meta-analysis. Rheumatol Int. 2021 Oct;41(10):1729-1742. doi: 10.1007/s00296-021-04958-5. Epub 2021 Jul 23. PMID: 34302232.
Copy Download .nbib Format: NLM
Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience.

Rheumatology international

Üsküdar Cansu D, Üsküdar Teke H, Cansu GB, Korkmaz C.
PMID: 34213581
Rheumatol Int. 2021 Sep;41(9):1617-1624. doi: 10.1007/s00296-021-04935-y. Epub 2021 Jul 02.

Hyperferritinemia may develop due to various reasons such as inflammation, infection, or malignancy. The purpose of the study to explore the prevalence and to figure out the causes of general hyperferritinemia and extreme hyperferritinemia as detected through the ferritin...

Cite
Üsküdar Cansu D, Üsküdar Teke H, Cansu GB, et al. Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience. Rheumatol Int. 2021;41(9):1617-1624doi: 10.1007/s00296-021-04935-y.
Üsküdar Cansu, D., Üsküdar Teke, H., Cansu, G. B., & Korkmaz, C. (2021). Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience. Rheumatology international, 41(9), 1617-1624. https://doi.org/10.1007/s00296-021-04935-y
Üsküdar Cansu, Döndü, et al. "Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience." Rheumatology international vol. 41,9 (2021): 1617-1624. doi: https://doi.org/10.1007/s00296-021-04935-y
Üsküdar Cansu D, Üsküdar Teke H, Cansu GB, Korkmaz C. Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience. Rheumatol Int. 2021 Sep;41(9):1617-1624. doi: 10.1007/s00296-021-04935-y. Epub 2021 Jul 02. PMID: 34213581; PMCID: PMC8252695.
Copy Download .nbib Format: NLM
Long-term survival of biological therapy in psoriatic arthritis: 18-year analysis of a cohort in a tertiary hospital.

Rheumatology international

Mateo Soria L, Prior-Español Á, Grigorov MM, Holgado-Pérez S, Aparicio-Espinar M, Martinez-Morillo M, Olivé-Marqués A.
PMID: 34191046
Rheumatol Int. 2021 Jun 30; doi: 10.1007/s00296-021-04928-x. Epub 2021 Jun 30.

To study retention of biologic disease-modifying anti-rheumatic drugs (bDMARDs) or apremilast and potential predictors of lack of response in patients with psoriatic arthritis (PsA). A single-center retrospective analysis of PsA patients who received  ≥  1 bDMARD or apremilast during...

Cite
Mateo Soria L, Prior-Español Á, Grigorov MM, et al. Long-term survival of biological therapy in psoriatic arthritis: 18-year analysis of a cohort in a tertiary hospital. Rheumatol Int. 2021;doi: 10.1007/s00296-021-04928-x.
Mateo Soria, L., Prior-Español, �. �., Grigorov, M. M., Holgado-Pérez, S., Aparicio-Espinar, M., Martinez-Morillo, M., & Olivé-Marqués, A. (2021). Long-term survival of biological therapy in psoriatic arthritis: 18-year analysis of a cohort in a tertiary hospital. Rheumatology international, . https://doi.org/10.1007/s00296-021-04928-x
Mateo Soria, Lourdes, et al. "Long-term survival of biological therapy in psoriatic arthritis: 18-year analysis of a cohort in a tertiary hospital." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-04928-x
Mateo Soria L, Prior-Español Á, Grigorov MM, Holgado-Pérez S, Aparicio-Espinar M, Martinez-Morillo M, Olivé-Marqués A. Long-term survival of biological therapy in psoriatic arthritis: 18-year analysis of a cohort in a tertiary hospital. Rheumatol Int. 2021 Jun 30; doi: 10.1007/s00296-021-04928-x. Epub 2021 Jun 30. PMID: 34191046.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 344 entries